Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer’s disease

[1]  T. Deierborg,et al.  Voluntary running does not reduce neuroinflammation or improve non-cognitive behavior in the 5xFAD mouse model of Alzheimer’s disease , 2020, Scientific Reports.

[2]  A. Cristofano,et al.  Physical exercise for prevention of dementia (EPD) study: background, design and methods , 2019, BMC Public Health.

[3]  S. Kern,et al.  Cognitive and physical activity and dementia , 2019, Neurology.

[4]  B. Sheehan,et al.  Dementia And Physical Activity (DAPA) trial of moderate to high intensity exercise training for people with dementia: randomised controlled trial , 2018, British Medical Journal.

[5]  K. Michaëlsson,et al.  Survival and incidence of cardiovascular diseases in participants in a long-distance ski race (Vasaloppet, Sweden) compared with the background population , 2018, European heart journal. Quality of care & clinical outcomes.

[6]  H. Soininen,et al.  Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial , 2018, JAMA neurology.

[7]  T. Deierborg,et al.  Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD , 2018, Scientific Reports.

[8]  L. Tan,et al.  Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies , 2017, BMJ Open.

[9]  G. Alexopoulos,et al.  Strategies for dementia prevention: latest evidence and implications , 2017, Therapeutic advances in chronic disease.

[10]  Jean-François Dartigues,et al.  Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study , 2017, British Medical Journal.

[11]  Alina Solomon,et al.  Physical Activity and Alzheimer’s Disease: A Systematic Review , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  David T. Jones,et al.  Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals , 2017, JAMA neurology.

[13]  S. Lehéricy,et al.  Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial , 2017, The Lancet Neurology.

[14]  Mahmoud Torabinejad,et al.  Cytotoxicity and Antimicrobial Effects of a New Fast-Set MTA , 2017, BioMed research international.

[15]  C. Guure,et al.  Impact of Physical Activity on Cognitive Decline, Dementia, and Its Subtypes: Meta-Analysis of Prospective Studies , 2017, BioMed research international.

[16]  Eric E. Smith,et al.  Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development , 2016, Alzheimer's & dementia.

[17]  K. Blennow,et al.  Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease , 2016, Dementia and Geriatric Cognitive Disorders.

[18]  T. Deierborg,et al.  Forced treadmill exercise can induce stress and increase neuronal damage in a mouse model of global cerebral ischemia , 2016, Neurobiology of Stress.

[19]  Edo Richard,et al.  Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial , 2016, The Lancet.

[20]  C. DeCarli,et al.  Physical Activity, Brain Volume, and Dementia Risk: The Framingham Study , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[21]  S. Ryan,et al.  Exercise as a pro-cognitive, pro-neurogenic and anti-inflammatory intervention in transgenic mouse models of Alzheimer’s disease , 2016, Ageing Research Reviews.

[22]  K. Michaëlsson,et al.  Risk of recurrent ischaemic events after myocardial infarction in long-distance ski race participants , 2016, European journal of preventive cardiology.

[23]  R. Ossenkoppele,et al.  The effect of physical activity on cognitive function in patients with dementia: A meta-analysis of randomized control trials , 2016, Ageing Research Reviews.

[24]  D. Holtzman,et al.  A spectrum of exercise training reduces soluble Aβ in a dose-dependent manner in a mouse model of Alzheimer's disease , 2016, Neurobiology of Disease.

[25]  G. Hanson,et al.  Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits , 2015, The international journal of neuropsychopharmacology.

[26]  C. Cotman,et al.  Moderate to high-intensity physical exercise in patients with Alzheimer’s disease , 2015, Alzheimer's & Dementia.

[27]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[28]  Kristine Yaffe,et al.  Potential for primary prevention of Alzheimer's disease: an analysis of population-based data , 2014, The Lancet Neurology.

[29]  F. Roman,et al.  Onset of hippocampus‐dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease , 2014, Hippocampus.

[30]  J. Veerman,et al.  Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies , 2014, BMC Public Health.

[31]  F. Schmitt,et al.  Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models , 2014, Front. Genet..

[32]  P. Brundin,et al.  Nonsteroidal selective androgen receptor modulators and selective estrogen receptor β agonists moderate cognitive deficits and amyloid-β levels in a mouse model of Alzheimer's disease. , 2013, ACS chemical neuroscience.

[33]  G. Hu,et al.  Aerobic Exercise Combined with Antioxidative Treatment does not Counteract Moderate‐ or Mid‐Stage Alzheimer‐Like Pathophysiology of APP/PS1 Mice , 2013, CNS neuroscience & therapeutics.

[34]  O. Franco,et al.  The association between physical activity and dementia in an elderly population: the Rotterdam Study , 2013, European Journal of Epidemiology.

[35]  M. Staufenbiel,et al.  Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice , 2012, Neurobiology of Aging.

[36]  Mark A Mintun,et al.  Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition. , 2012, Archives of neurology.

[37]  S. Black,et al.  Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[38]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[39]  Dag Aarsland,et al.  Is physical activity a potential preventive factor for vascular dementia? A systematic review , 2010, Aging & mental health.

[40]  D. Steffens,et al.  Midlife activity predicts risk of dementia in older male twin pairs , 2008, Alzheimer's & Dementia.

[41]  M. Hamer,et al.  Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence , 2008, Psychological Medicine.

[42]  G. Ravaglia,et al.  Physical activity and dementia risk in the elderly , 2008, Neurology.

[43]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[44]  B. Winblad,et al.  Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease , 2005, The Lancet Neurology.

[45]  Lewis H Kuller,et al.  Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. , 2005, American journal of epidemiology.

[46]  J. Wesson Ashford,et al.  ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.

[47]  A. Ahlbom,et al.  Mortality amongst participants in Vasaloppet: a classical long‐distance ski race in Sweden , 2003, Journal of internal medicine.

[48]  Y. Mimori,et al.  Association Between Dementia and Midlife Risk Factors: the Radiation Effects Research Foundation Adult Health Study , 2003, Journal of the American Geriatrics Society.

[49]  G. Berglund,et al.  The Malmö diet and cancer study: representativity, cancer incidence and mortality in participants and non‐participants , 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[50]  G. Berglund,et al.  Design and feasibility , 1993 .

[51]  L. Fratiglioni,et al.  Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention. , 2010, Journal of Alzheimer's Disease.

[52]  L. Fratiglioni,et al.  Physical exercise at midlife and risk of dementia three decades later: a population-based study of Swedish twins. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[53]  A. Ahlbom,et al.  [Skiers in the long-distance ski race invest in their health]. , 2007, Lakartidningen.

[54]  K. Jellinger.  Clinicopathological analysis of dementia disorders in the elderly--an update. , 2006, Journal of Alzheimer's disease : JAD.

[55]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[56]  G. Berglund,et al.  The Malmo Diet and Cancer Study. Design and feasibility. , 1993, Journal of internal medicine.

[57]  A S Leon,et al.  A questionnaire for the assessment of leisure time physical activities. , 1978, Journal of chronic diseases.